Global Transfection Technologies Market: 2012-2017

1. Introduction

1.1 Key Take-Aways
1.2 Report Scope
1.3 Research Methodology
1.4 Key Data Points From Secondary Sources
1.5 Key Data Points From Primary Sources

2. Executive Summary

3. Transfection Technologies - Technology Landscape Analysis

3.1 Technology Overview (Introduction, Evolution And Market Segmentation)
3.2 Technology Value Chain Analysis (With Technology Capability/Maturity Levels)
3.3 Comparative Analysis Of Transfection Methods (Physical, Biochemical And Viral)

3.4 Applications
3.4.1 Therapeutic Delivery
3.4.1.1 Bio-Therpeutics (Gene Delivery, Protein Delivery)
3.4.1.2 Electrochemotherapy And Electro-Immunotherapy
3.4.2 Bio-Medical Research
3.4.2.1 Transgenic Models
3.4.2.2 Gene And Protein Expression Studies
3.4.2.3 Cancer Research
3.4.2.4 Cell Based Microarrays For Drug Discovery And Development
3.4.3 Protein Production (Recombinant Protein, Vaccines)

4. Transfection - Market Landscape Analysis

4.1 Global Market Forecast
4.1.1 By Geography
4.1.2 By Products
4.1.3 By Application
4.1.4 By Technology

4.2 Market Dynamics
4.2.1 Drivers (With Timeline)
4.2.2 Restraints/Challenges (With Timeline)
4.2.3 Emerging Trends

5. Global R&D Portfolio Analysis

5.1 Key R&D Networks - Current & Emerging - This Segment Will Include University - Incubator Divisions; Company - Vc Funded Corporate Incubator Divisions)
5.2 Universities With Potential Technologies For Licensing/Tech Transfer; Form Spin Offs

6. Investment/Funding Analysis

6.1 Investment Climate Assessment
6.2 Investments On Transfection

7. Transfection - Diffusion Analysis

7.1 Technology Adoption And Development-Geographical Analysis
7.1.1 Introduction
7.1.2 North America
7.1.3 Europe
7.1.3.1 Key Research Areas Based On Electroporation In European Union
7.1.3.2 Funding And Development Activities In European Union
7.1.4 Apac
7.1.5 Row

8. Competitive Landscape

8.1 Mergers & Acquisitions, 2007 - 2012
8.2 Partnerships & Collaborations, 2007 - 2012
8.3 New Product/Technology Development Initiatives
8.4 Market Share Analysis Of Key Players - 2012

9. Opportunity Evaluation And Technology Benchmarking/Roadmapping

9.1 Scenario Modeling
9.2 Evaluation Of Emerging Opportunities
9.3 Technology Benchmarking Based On Multicriteria Decision Making
9.4 Technology Road Mapping

10. Patent Analysis

11. Analyst Insights And Recommendations

11.1 Introduction
11.2 Technology Management Strategies

12. Company Profiles

12.1 Life Technologies Corporation
12.2 Lonza Group Ltd.
12.3 Promega Corporation
12.4 Sigma Aldrich Corporation
12.5 Thermo Fisher Scientific Inc.
12.6 Bio-Rad Laboratories Inc.
12.7 Roche Applied Science
12.8 Qiagen N.V.,
12.9 Inovio Pharmaceuticals Inc.,
12.10 Polyplus Transfection S.A.
12.11 Mirus Bio Llc.
12.12 Clonetech Laboratories, Inc.
12.13 Signagen Laboratories
12.14 Maxcyte, Inc.
12.15 Nanotherics
12.16 Genlantis
12.17 Techulon Inc.,
12.18 Deliverics Ltd.
12.19 Oz Biosciences
12.20 Molecular Transfer Inc.,
12.21 Altogen Biosystems
12.22 Promokine Gmbh

13. Appendix

14. Glossary

List of Tables

Table 1 Mapping Of Technology Capability And Maturity
Table 2 Global Transfection Market Revenue, 2012-2017 ($ Million)
Table 3 Global Transfection Market By Geography, 2012-2017 ($ Million)
Table 4 Global Transfection Market Revenue By Products, 2012-2017 ($ Million)
Table 5 Global Transfection Market Revenue By Applications 2012-2017 ($ Million)
Table 6 Global Transfection Market Revenue By Technolgy 2012-2017 ($ Million)
Table 7 Market Dynamics - Drivers Impact Time Line
Table 8 Market Dynamics - Restraints Impact Timeline
Table 9 Opportunity Strategic Evaluation Analysis

List of Figures

Figure 1 Research Methodology
Figure 2 Global Transfection Market Revenue, 2012-2017 ($ Million)
Figure 3 Technology Overview
Figure 4 Technology Value Chain Analysis
Figure 5 Technology Capability And Maturity
Figure 6 Technology Life Cycle Analysis
Figure 7 Global Transfection Market Revenue, 2012-2017 ($ Million)
Figure 8 Global Transfection Market - Growth Rate By Geography 2012 - 2017
Figure 9 Global Transfection Market Share By Geography 2012
Figure 10 Global Transfection Market Revenue By Geography, 2012-2017 ($ Million)
Figure 11 Global Transfection Market - Growth Rate By Products 2012 - 2017
Figure 12 Global Transfection Market Share By Products 2012
Figure 13 Global Transfection Market Revenue By Products, 2012-2017 ($ Million)
Figure 14 Global Transfection Market - Growth Rate By Applications 2012 - 2017
Figure 15 Global Transfection Market Share By Applications 2012
Figure 16 Global Transfection Market Revenue By Applications, 2012-2017($ Million)
Figure 17 Global Transfection Market - Growth Rate By Technology 2012 - 2017
Figure 18 Global Transfection Market Share By Technology 2012
Figure 19 Global Transfection Market Revenue By Technology 2012-2017 ($ Million)
Figure 20 Global Research Portfolio-Research And Development Network
Figure 21 Attractive Forces For Increased Market Value
Figure 22 Adoption Rate Of Electrochemotherapy (2006-2010)
Figure 23 Funding Landscape In Eu
Figure 24 Market Share Analysis Of Key Players - 2012
Figure 25 Opportunity Strategic Evaluation Analysis
Figure 26 Prioritization Of Transfection Technologies For Future Adoption
Figure 27 Priority Values For Level 0
Figure 28 Comparison Of Technology Based On Level 0 Criteria
Figure 29 Technology Prioritization
Figure 30 No Of Patents Published Between The Year 2007-2012
Figure 31 Percentage Distribution: Reagents Vs Physical (2007-2012)